NO880934D0 - Fremgangsmaate for paavisning av hiv eller annet virus med lignende klinisk virkning. - Google Patents

Fremgangsmaate for paavisning av hiv eller annet virus med lignende klinisk virkning.

Info

Publication number
NO880934D0
NO880934D0 NO880934A NO880934A NO880934D0 NO 880934 D0 NO880934 D0 NO 880934D0 NO 880934 A NO880934 A NO 880934A NO 880934 A NO880934 A NO 880934A NO 880934 D0 NO880934 D0 NO 880934D0
Authority
NO
Norway
Prior art keywords
pathway
rnase
hiv
aids
biochemical
Prior art date
Application number
NO880934A
Other languages
English (en)
Other versions
NO880934L (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO880934D0 publication Critical patent/NO880934D0/no
Publication of NO880934L publication Critical patent/NO880934L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO880934A 1987-03-03 1988-03-02 Fremgangsmaate for paavisning av hiv eller annet virus med lignende klinisk virkning. NO880934L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (2)

Publication Number Publication Date
NO880934D0 true NO880934D0 (no) 1988-03-02
NO880934L NO880934L (no) 1988-09-05

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880934A NO880934L (no) 1987-03-03 1988-03-02 Fremgangsmaate for paavisning av hiv eller annet virus med lignende klinisk virkning.

Country Status (20)

Country Link
EP (1) EP0285263B1 (no)
JP (1) JPH0675520B2 (no)
KR (1) KR880011593A (no)
AT (1) ATE107964T1 (no)
AU (1) AU618525B2 (no)
CA (1) CA1337278C (no)
DE (1) DE3850428T2 (no)
DK (1) DK112888A (no)
ES (1) ES2058252T3 (no)
FI (1) FI880959A (no)
IE (1) IE66831B1 (no)
IL (1) IL85576A0 (no)
MX (1) MX173802B (no)
NO (1) NO880934L (no)
NZ (1) NZ223721A (no)
OA (1) OA08720A (no)
PH (1) PH30882A (no)
PT (1) PT86878B (no)
RU (1) RU2049336C1 (no)
ZA (1) ZA881471B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
EP0350151B1 (en) * 1988-07-07 1994-03-30 Hem Pharmaceuticals Corp. Diagnosing and treating chronic fatigue syndrome
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
US11859234B2 (en) 2016-05-06 2024-01-02 The Trustees Of Princeton University Method of monitoring RNase L activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
CA1337278C (en) 1995-10-10
FI880959A (fi) 1988-09-04
ES2058252T3 (es) 1994-11-01
FI880959A0 (fi) 1988-03-02
DE3850428T2 (de) 1994-11-24
DK112888A (da) 1988-09-04
AU1256388A (en) 1988-09-01
PT86878B (pt) 1992-05-29
DK112888D0 (da) 1988-03-02
AU618525B2 (en) 1992-01-02
OA08720A (en) 1989-03-31
IE66831B1 (en) 1996-02-07
PH30882A (en) 1997-12-23
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
EP0285263B1 (en) 1994-06-29
JPS63309200A (ja) 1988-12-16
ZA881471B (en) 1988-12-28
EP0285263A3 (en) 1990-04-18
IE880587L (en) 1988-09-03
IL85576A0 (en) 1988-08-31
NZ223721A (en) 1991-02-26
RU2049336C1 (ru) 1995-11-27
ATE107964T1 (de) 1994-07-15
NO880934L (no) 1988-09-05
EP0285263A2 (en) 1988-10-05
PT86878A (pt) 1988-04-01
JPH0675520B2 (ja) 1994-09-28
DE3850428D1 (de) 1994-08-04

Similar Documents

Publication Publication Date Title
Brockman et al. Heterocyclic thiosemicarbazones: correlation between structure, inhibition of ribonucleotide reductase, and inhibition of DNA viruses
US4880782A (en) Method of treating viral infections in humans and compositions therefor
GB2199328A (en) Translation of mrna
AU6497694A (en) Method for selective inactivation of viral replication
SE9103183L (sv) Virus-antikroppskomplex
NO880934D0 (no) Fremgangsmaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
DK449888A (da) Anvendelse af dsrna til fremstilling af et parenteralt laegemiddel der forstaerker immunforsvaret
AU590817B2 (en) Antiviral combinations
ZA931647B (en) Therapeutic nucleosides
EP0135713A3 (en) Antiviral combinations
SE8601435L (sv) Aktivt pansar
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
ES468363A1 (es) Proceso para la fabricacion de un preparado destinado al tra-tamiento de herpes-zoster.
ATE178335T1 (de) Therapeutische nukleoside der 2',3'-dideoxy-3'- fluor -purin reihe
FI923020A0 (fi) Inte a inte b-sekvenser.
IT9047997A1 (it) Sistema per il dispiegamento di superfici aerodinamiche (aerofoil) su proiettili, missili o simili
AP1592A (en) Viral drug susceptibility testing
SE8702004L (sv) Rotationsprojektil med ett ihaligt nosparti
ES2007094A6 (es) Procedimiento para la preparacion de 3 -c- ciano-2,3 -didesoxinucleosido.
Baker Illuminated models of pre-erythrocythic schiozogony of five malaria parasites
RU2003136244A (ru) Штамм сод вируса тяжелого острого респираторного синдрома рода coronavirus, предназначенный для разработки средств и методов биологической защиты
JPS6447398A (en) Selection of blood of blood preparation contaminated with human lymphocytophilic virus
SU1545614A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита